Oppenheimer Starts Vera Therapeutics (VERA) at Outperform, 'We are bullish'

January 24, 2024 4:02 PM EST Send to a Friend
(Updated - January 24, 2024 4:07 PM EST)

Oppenheimer analyst Justin Kim initiates coverage on Vera Therapeutics (NASDAQ: VERA) ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login